Molecular basis of chronic non-spherocytic haemolytic anaemia

A new G6PD variant (393 Arg → His) with abnormal K(m)(G6P) and marked in vivo instability

S. Filosa, V. Calabro, D. Vallone, V. Poggi, P. Mason, D. Pagnini, F. Alfinito, B. Rotoli, G. Martini, L. Luzzatto, G. Battistuzzi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

More than 80 genetic variants of glucose-6-phosphate dehydrogenase (G6PD) are associated with chronic non-spherocytic haemolytic anaemia (CNSHA). In order to help clarify the molecular basis of this association, we have carried out a detailed biochemical and genetic characterization of two G6PD deficient brothers affected by CNSHA. The G6PD from the two patients has altered electrophoretic mobility, abnormally elevated Michaelis constant (K(m)) for G6P, and extreme instability in vivo and in vitro. By comparison with published information we found that this is a new G6PD variant which we have designated G6PD Portici. The entire coding region of the gene has been sequenced, and a single point mutation, a G → A transition, was found at position 1178 in exon X, causing a substitution of histidine for arginine at residue 393 in the polypeptide chain. By polymerase chain reaction (PCR) amplification followed by diagnostic restriction enzyme analysis and allele-specific oligonucleotide hybridization we have demonstrated the inheritance of this mutation in the patient's family. Our results support the notion of a causative link between this mutation in the G6PD gene and CNSHA. Our data, in combination with previous data in the literature, suggest that the three-dimensional structure of G6PD is such as to cause interaction in the binding of its two substrates, G6P and NADP.

Original languageEnglish
Pages (from-to)111-116
Number of pages6
JournalBritish Journal of Haematology
Volume80
Issue number1
Publication statusPublished - 1992

Fingerprint

Glucosephosphate Dehydrogenase
Hemolytic Anemia
Restriction Mapping
Mutation
glucose-6-phosphate dehydrogenase A-
NADP
Point Mutation
Histidine
Oligonucleotides
Genes
Arginine
Siblings
Molecular Biology
Exons
Alleles
Polymerase Chain Reaction
Peptides

ASJC Scopus subject areas

  • Hematology

Cite this

Molecular basis of chronic non-spherocytic haemolytic anaemia : A new G6PD variant (393 Arg → His) with abnormal K(m)(G6P) and marked in vivo instability. / Filosa, S.; Calabro, V.; Vallone, D.; Poggi, V.; Mason, P.; Pagnini, D.; Alfinito, F.; Rotoli, B.; Martini, G.; Luzzatto, L.; Battistuzzi, G.

In: British Journal of Haematology, Vol. 80, No. 1, 1992, p. 111-116.

Research output: Contribution to journalArticle

Filosa, S, Calabro, V, Vallone, D, Poggi, V, Mason, P, Pagnini, D, Alfinito, F, Rotoli, B, Martini, G, Luzzatto, L & Battistuzzi, G 1992, 'Molecular basis of chronic non-spherocytic haemolytic anaemia: A new G6PD variant (393 Arg → His) with abnormal K(m)(G6P) and marked in vivo instability', British Journal of Haematology, vol. 80, no. 1, pp. 111-116.
Filosa, S. ; Calabro, V. ; Vallone, D. ; Poggi, V. ; Mason, P. ; Pagnini, D. ; Alfinito, F. ; Rotoli, B. ; Martini, G. ; Luzzatto, L. ; Battistuzzi, G. / Molecular basis of chronic non-spherocytic haemolytic anaemia : A new G6PD variant (393 Arg → His) with abnormal K(m)(G6P) and marked in vivo instability. In: British Journal of Haematology. 1992 ; Vol. 80, No. 1. pp. 111-116.
@article{c0f6cdfb67464842bfaedd2feca2b9ad,
title = "Molecular basis of chronic non-spherocytic haemolytic anaemia: A new G6PD variant (393 Arg → His) with abnormal K(m)(G6P) and marked in vivo instability",
abstract = "More than 80 genetic variants of glucose-6-phosphate dehydrogenase (G6PD) are associated with chronic non-spherocytic haemolytic anaemia (CNSHA). In order to help clarify the molecular basis of this association, we have carried out a detailed biochemical and genetic characterization of two G6PD deficient brothers affected by CNSHA. The G6PD from the two patients has altered electrophoretic mobility, abnormally elevated Michaelis constant (K(m)) for G6P, and extreme instability in vivo and in vitro. By comparison with published information we found that this is a new G6PD variant which we have designated G6PD Portici. The entire coding region of the gene has been sequenced, and a single point mutation, a G → A transition, was found at position 1178 in exon X, causing a substitution of histidine for arginine at residue 393 in the polypeptide chain. By polymerase chain reaction (PCR) amplification followed by diagnostic restriction enzyme analysis and allele-specific oligonucleotide hybridization we have demonstrated the inheritance of this mutation in the patient's family. Our results support the notion of a causative link between this mutation in the G6PD gene and CNSHA. Our data, in combination with previous data in the literature, suggest that the three-dimensional structure of G6PD is such as to cause interaction in the binding of its two substrates, G6P and NADP.",
author = "S. Filosa and V. Calabro and D. Vallone and V. Poggi and P. Mason and D. Pagnini and F. Alfinito and B. Rotoli and G. Martini and L. Luzzatto and G. Battistuzzi",
year = "1992",
language = "English",
volume = "80",
pages = "111--116",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "1",

}

TY - JOUR

T1 - Molecular basis of chronic non-spherocytic haemolytic anaemia

T2 - A new G6PD variant (393 Arg → His) with abnormal K(m)(G6P) and marked in vivo instability

AU - Filosa, S.

AU - Calabro, V.

AU - Vallone, D.

AU - Poggi, V.

AU - Mason, P.

AU - Pagnini, D.

AU - Alfinito, F.

AU - Rotoli, B.

AU - Martini, G.

AU - Luzzatto, L.

AU - Battistuzzi, G.

PY - 1992

Y1 - 1992

N2 - More than 80 genetic variants of glucose-6-phosphate dehydrogenase (G6PD) are associated with chronic non-spherocytic haemolytic anaemia (CNSHA). In order to help clarify the molecular basis of this association, we have carried out a detailed biochemical and genetic characterization of two G6PD deficient brothers affected by CNSHA. The G6PD from the two patients has altered electrophoretic mobility, abnormally elevated Michaelis constant (K(m)) for G6P, and extreme instability in vivo and in vitro. By comparison with published information we found that this is a new G6PD variant which we have designated G6PD Portici. The entire coding region of the gene has been sequenced, and a single point mutation, a G → A transition, was found at position 1178 in exon X, causing a substitution of histidine for arginine at residue 393 in the polypeptide chain. By polymerase chain reaction (PCR) amplification followed by diagnostic restriction enzyme analysis and allele-specific oligonucleotide hybridization we have demonstrated the inheritance of this mutation in the patient's family. Our results support the notion of a causative link between this mutation in the G6PD gene and CNSHA. Our data, in combination with previous data in the literature, suggest that the three-dimensional structure of G6PD is such as to cause interaction in the binding of its two substrates, G6P and NADP.

AB - More than 80 genetic variants of glucose-6-phosphate dehydrogenase (G6PD) are associated with chronic non-spherocytic haemolytic anaemia (CNSHA). In order to help clarify the molecular basis of this association, we have carried out a detailed biochemical and genetic characterization of two G6PD deficient brothers affected by CNSHA. The G6PD from the two patients has altered electrophoretic mobility, abnormally elevated Michaelis constant (K(m)) for G6P, and extreme instability in vivo and in vitro. By comparison with published information we found that this is a new G6PD variant which we have designated G6PD Portici. The entire coding region of the gene has been sequenced, and a single point mutation, a G → A transition, was found at position 1178 in exon X, causing a substitution of histidine for arginine at residue 393 in the polypeptide chain. By polymerase chain reaction (PCR) amplification followed by diagnostic restriction enzyme analysis and allele-specific oligonucleotide hybridization we have demonstrated the inheritance of this mutation in the patient's family. Our results support the notion of a causative link between this mutation in the G6PD gene and CNSHA. Our data, in combination with previous data in the literature, suggest that the three-dimensional structure of G6PD is such as to cause interaction in the binding of its two substrates, G6P and NADP.

UR - http://www.scopus.com/inward/record.url?scp=0026541412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026541412&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 111

EP - 116

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -